BIOFIRE® Respiratory Panel (RP, RP2 and RP2 plus), identifying between 20 and 22 respiratory viruses and bacteria performed directly on nasopharyngeal swabs in transport media.

BIOFIRE ® FILMARRAY ® Respiratory Panel 2 plus (RP2plus), CE marked and FDA cleared, a comprehensive panel of 22 respiratory viruses and bacteria performed directly on nasopharyngeal ...

Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that the BIOFIRE Respiratory Panel 2.1 plus (RP2.1plus) is CE marked. The ...

BioFire currently offers the FDA-cleared and CE IVD marked FilmArray Respiratory Panel (RP), and the CE IVD marked BCID Panel, both of which represent a significant advancement in user ...

The US Food and Drug Administration (FDA) granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification ...

“In this case, the predicate device is the BioFire Respiratory Panel 2.1 (RP2.1), which is a panel that tests for the presence of nucleic acids from SARS-CoV-2 and 21 other pathogens that cause ...

BioFire Diagnostics, Inc. today announced that it has signed a competitive prototyping contract with the Department of the Army for Increment 1 of the Next Generation Diagnostics System (NGDS ...

bioMérieux, a world leader in the field of in vitro diagnostics, has achieved a significant milestone with the Health Canada approval of the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel.

BioFire's FilmArray device includes several molecular diagnostic panels, two of which have already been cleared by the FDA: respiratory and blood culture. Its GI panel tests for common pathogens ...

But because of the fall and winter seasons bringing on the possibility of new respiratory illnesses for individuals in the community, a respiratory panel will be used for patients at both ...

Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary specialized in molecular syndromic infectious ...

Biomerieux: BIOFIRE® Respiratory Panel 2.1 (RP2.1) with SARS-CoV-2 Obtains FDA Emergency Use Authorization By Reuters May 4, 2020 5:07 AM UTC Updated May 4, 2020 ...